FNY Partners Fund’s Acer Therapeutics Inc ACER Stock Holding History

FNY Partners Fund’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-192	Closed	-$1K	–	1244
2017 Q1	$1K	Buy	+192	New	+$1.89K	﹤0.01%	1365

Other funds holding ACER

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FNY Partners Fund's ACER Position: Q2 2017 in Review

FNY Partners Fund sold out of Acer Therapeutics Inc (ACER) in Q2 2017, closing a stake of 192 shares — an estimated $1K sold.

FNY Partners Fund first reported a position in ACER in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 13 funds tracked by Wall St. Rank hold ACER as of Q2 2017.

FNY Partners Fund reported no remaining Acer Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 192 Acer Therapeutics Inc shares in Q2 2017, an estimated $1K.
FNY Partners Fund first reported a position in Acer Therapeutics Inc in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Acer Therapeutics Inc position peaked at $1K in Q1 2017.
13 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.